High levels of ecto-5'-nucleotidase (CD73) have been implicated in immune 40 suppression and tumor progression, and have also been observed in cancer 41 patients who progress on anti-PD-1 immunotherapy. While regulatory T cells can 42 express CD73 and inhibit T cell responses via the production of adenosine, less is 43 known about CD73 expression in other immune cell populations. We found that 44 tumor-infiltrating NK cells upregulate CD73 expression and the frequency of these 45 CD73+ NK cells correlated with larger tumor size in breast cancer patients. In 46 addition, the expression of multiple alternative immune checkpoint receptors 47 including LAG-3, VISTA, PD-1, and PD-L1 was significantly higher in CD73 positive 48 NK cells than in CD73 negative NK cells. Mechanistically, NK cells transport CD73 49 in intracellular vesicles to the cell surface and the extracellular space via actin 50 polymerization-dependent exocytosis upon engagement of 4-1BBL on tumor cells. 51 These CD73 positive NK cells undergo transcriptional reprogramming and 52 upregulate IL10 production via STAT3 transcriptional activity, suppressing CD4 T 53 cell proliferation and IFNg production. Taken together, our results support that 54 tumors can hijack NK cells as a means to escape immunity and that CD73 55 expression defines an inducible population of NK cells with immune regulatory 56 properties within the tumor microenvironment.
1D and E). Taken together, these observations show that CD73+ NK cells were 162 found only in the tumor microenvironment and that the frequency of these cells 163 correlates with larger tumor size in patients with breast cancer. Based on our observations that tumor-infiltrating NK cells with CD73 expression 199 also co-expressed higher levels of immune checkpoints, we hypothesized that Figure 4A and Supplementary Table S2 ) 279 When filtered for immune-related genes, CD73+ NK cells generally upregulated 280 genes associated with immune activation, chemokines, CSF1 (encoding M-CSF) 281 and CSF2 (encoding GM-CSF).( Figure 5D ) In analyzing the top 100 upregulated 282 genes, functional nodes mostly related to lymphocyte activation were identified.
283
( Figure 5E ) Of interest, CD73+ NK cells upregulated genes that are related to IL-10 284 production and granulocyte chemotaxis, both of which could potentially play a role 285 in immune suppression.
287
To validate and substantiate our findings from these co-culture assays, we further 288 isolated tumor infiltrating NK cells from two breast tumors and two sarcomas for 289 gene expression analysis. Not only did these experiments confirm the upregulation 290 of IL-10 gene expression but also that several known targets that can be regulated Figure 4B and Supplementary Figure 5F ), NK 320 cells were co-cultured with tumors cells and assayed for their production of IL-10. 321 Indeed, upon co-culture with tumor cells, a significant upregulation of IL-10 322 production by CD73+ NK cells compared with CD73-NK cells were observed. In 323 addition, CD73+ NK cells also produced higher levels of TGF-b compared with 324 CD73-NK cells, and the capacity of CD73+ NK cells to produce these two 325 cytokines was significantly reduced in the presence of GPB730. In addition, the 326 production of TGF-b was significantly inhibited only at high doses of GPB730 327 during co-culture, whereas IL-10 production was inhibited by pre-treating NK cells Since GPB730 pre-treated NK cells showed reduced suppression of CD4 T cell 336 IFNg production ( Figure 6G ), we further investigated if either production of IL-10 or 337 TGFb was the direct underlying suppressive mechanism of CD4 T cells by CD73+ 338 NK cells. Suppression assays performed in the presence of neutralizing antibodies 339 to IL-10 restored the production of IFNg by CD4 T cells, whereas the presence of 340 the TGF-b1 receptor inhibitor Galunisertib did not. (Figure 6H and 6I) These results
341
show that CD73+ NK cells upregulate STAT3 activity due to immune activation 342 resulting in the production IL-10 that inhibits IFNg production by CD4 T cells.
Under physiological conditions, purinergic receptors play an important role for 345 lineage commitment, tissue repair, as well as to confer immune tolerance. (2, 31) 346 However, extracellular adenosine could be dysregulated by CD73-overexpressing 347 tumors contributing to resistance against cytostatic drugs and immune therapies.(7, 348 26, 32, 33) Despite the extensive efforts to introduce CD73 inhibitors into the clinic, 349 the complexity in the regulation of this ectonucleotidase is not well understood.(34) 350 We observed that the predictive value of tumor NT5E expression could be prior studies have demonstrated that CTLA-4 and CD73 can be stored within 392 intracellular vesicles, we hypothesized and demonstrated that exocytosis was 393 involved in the underlying mechanism in which NK cells acquire CD73 expression.
394
(35, 43, 44) While CD73 is an enzyme that hydrolyses extracellular AMP on the cell 395 surface, we also showed that these tumor-experienced NK cells could also shed 396 CD73 protein into the extracellular space -a finding that might have clinical 397 relevance since soluble CD73 has been suggested to be a biomarker in patients 398 with metastatic cancer. (45) Another possibility that we did not explore was if these 399 NK cells could secrete exosomes expressing CD73 which was previously found to 400 be upregulated in serum from patients with head and neck squamous cell GolgiSTOP and GolgiPLUG (BD Biosciences) were used in combination for 24 519 hours within the tumor co-culture setting. Surface and intracellular cytokine staining 520 was then performed as described above. For staining of phosphorylated STAT3, 521 cells were fixated with Fix Buffer I (BD Biosciences) at 37 ºC for 10 minutes. Raw data were uploaded on Partek Flow for data analysis and GEO repository 593 (GSE125119). Raw reads were quality trimmed based on a minimum Phred quality 594 score of 20 and aligned to human genome assembly GRCh38 (hg38) using STAR 595 v2.5.3a with default parameters. Gene level counts were normalized using CPM 596 (counts per million) and quantified using a mixed-model ANOVA to account for 597 donor ID as a random effect and CD73+/-expression status as a fixed factor. 8456 598 differentially expressed genes were identified (See Supplementary Table S1 ) while 599 524 were significantly differentially expressed (p-value £0.05; Fold Change +/-2;
600
See Supplementary Table S2 ). A volcano plot ( Figure 5C ) was generated to 601 visualize the significance and the magnitude of changes in gene expression. From 602 the filtered 524 genes ( Supplementary Table S2 ), 74 immune-related genes were 603 identified from Gene Ontology Database; a heatmap was generated using 604 (unsupervised) hierarchical clustering (average linkage distance metric and 605 Euclidean point distance metric) ( Figure 5D ). Note binning of genes in the X-axis 606 for display purposes. Supplementary Table S2 ) with ClueGO plugin in Cytoscape.
610
Using default Cluego settings and GO term fusion, the 100 gene IDs were 611 submitted to query the GO-Biological process database (EBI, QuickGO, 15783 terms associated to 17268 unique genes, updated on 11/20/2017). Gene ontology 613 terms are presented as nodes and clustered together based on the term similarity. were mapped to the reference genome using HISAT2 software. Prior to differential 
